|
Fusion gene ID: 35359 |
FusionGeneSummary for SOD1_CXCL9 |
Fusion gene summary |
Fusion gene information | Fusion gene name: SOD1_CXCL9 | Fusion gene ID: 35359 | Hgene | Tgene | Gene symbol | SOD1 | CXCL9 | Gene ID | 6647 | 4283 |
Gene name | superoxide dismutase 1 | C-X-C motif chemokine ligand 9 | |
Synonyms | ALS|ALS1|HEL-S-44|IPOA|SOD|hSod1|homodimer | CMK|Humig|MIG|SCYB9|crg-10 | |
Cytomap | 21q22.11 | 4q21.1 | |
Type of gene | protein-coding | protein-coding | |
Description | superoxide dismutase [Cu-Zn]Cu/Zn superoxide dismutaseSOD, solubleepididymis secretory protein Li 44indophenoloxidase Asuperoxide dismutase 1, solublesuperoxide dismutase, cystolic | C-X-C motif chemokine 9chemokine (C-X-C motif) ligand 9gamma-interferon-induced monokinemonokine induced by gamma interferonmonokine induced by interferon-gammasmall-inducible cytokine B9 | |
Modification date | 20180527 | 20180523 | |
UniProtAcc | P00441 | Q07325 | |
Ensembl transtripts involved in fusion gene | ENST00000270142, ENST00000389995, ENST00000470944, | ENST00000264888, | |
Fusion gene scores | * DoF score | 3 X 3 X 1=9 | 3 X 2 X 3=18 |
# samples | 3 | 3 | |
** MAII score | log2(3/9*10)=1.73696559416621 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: SOD1 [Title/Abstract] AND CXCL9 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | SOD1 | GO:0000303 | response to superoxide | 16790527 |
Hgene | SOD1 | GO:0001819 | positive regulation of cytokine production | 15544046 |
Hgene | SOD1 | GO:0006801 | superoxide metabolic process | 12551919 |
Hgene | SOD1 | GO:0010033 | response to organic substance | 12921788 |
Hgene | SOD1 | GO:0032930 | positive regulation of superoxide anion generation | 18219391 |
Hgene | SOD1 | GO:0043085 | positive regulation of catalytic activity | 17324120 |
Hgene | SOD1 | GO:0043087 | regulation of GTPase activity | 18219391 |
Hgene | SOD1 | GO:0045541 | negative regulation of cholesterol biosynthetic process | 15473258 |
Hgene | SOD1 | GO:0045859 | regulation of protein kinase activity | 16254550 |
Hgene | SOD1 | GO:0050665 | hydrogen peroxide biosynthetic process | 15544046 |
Hgene | SOD1 | GO:0060047 | heart contraction | 9539776 |
Hgene | SOD1 | GO:0072593 | reactive oxygen species metabolic process | 24140062 |
Tgene | CXCL9 | GO:0006935 | chemotaxis | 12782716 |
Tgene | CXCL9 | GO:0030816 | positive regulation of cAMP metabolic process | 12782716 |
Tgene | CXCL9 | GO:0042127 | regulation of cell proliferation | 12782716 |
Tgene | CXCL9 | GO:0043950 | positive regulation of cAMP-mediated signaling | 12782716 |
Tgene | CXCL9 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol | 12782716 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | AW389351 | SOD1 | chr21 | 33040852 | + | CXCL9 | chr4 | 76924037 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-3UTR | ENST00000270142 | ENST00000264888 | SOD1 | chr21 | 33040852 | + | CXCL9 | chr4 | 76924037 | + |
5CDS-3UTR | ENST00000389995 | ENST00000264888 | SOD1 | chr21 | 33040852 | + | CXCL9 | chr4 | 76924037 | + |
3UTR-3UTR | ENST00000470944 | ENST00000264888 | SOD1 | chr21 | 33040852 | + | CXCL9 | chr4 | 76924037 | + |
Top |
FusionProtFeatures for SOD1_CXCL9 |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
SOD1 | CXCL9 |
Cytokine that affects the growth, movement, oractivation state of cells that participate in immune andinflammatory response. Chemotactic for activated T-cells. Binds toCXCR3. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for SOD1_CXCL9 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for SOD1_CXCL9 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for SOD1_CXCL9 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | SOD1 | P00441 | DB00988 | Dopamine | Superoxide dismutase [Cu-Zn] | small molecule | approved |
Hgene | SOD1 | P00441 | DB01064 | Isoprenaline | Superoxide dismutase [Cu-Zn] | small molecule | approved|investigational |
Hgene | SOD1 | P00441 | DB01593 | Zinc | Superoxide dismutase [Cu-Zn] | small molecule | approved|investigational |
Hgene | SOD1 | P00441 | DB00668 | Epinephrine | Superoxide dismutase [Cu-Zn] | small molecule | approved|vet_approved |
Top |
RelatedDiseases for SOD1_CXCL9 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | SOD1 | C1862939 | AMYOTROPHIC LATERAL SCLEROSIS 1 | 51 | CTD_human;UNIPROT |
Hgene | SOD1 | C0002736 | Amyotrophic Lateral Sclerosis | 24 | CTD_human;HPO;ORPHANET |
Hgene | SOD1 | C0007787 | Transient Ischemic Attack | 4 | CTD_human |
Hgene | SOD1 | C0035126 | Reperfusion Injury | 4 | CTD_human |
Hgene | SOD1 | C0011581 | Depressive disorder | 3 | CTD_human;HPO;PSYGENET |
Hgene | SOD1 | C0027746 | Nerve Degeneration | 3 | CTD_human;HPO |
Hgene | SOD1 | C0030567 | Parkinson Disease | 3 | CTD_human |
Hgene | SOD1 | C0007621 | Neoplastic Cell Transformation | 2 | CTD_human |
Hgene | SOD1 | C0011570 | Mental Depression | 2 | PSYGENET |
Hgene | SOD1 | C0020538 | Hypertensive disease | 2 | CTD_human |
Hgene | SOD1 | C0035304 | Retinal Degeneration | 2 | CTD_human |
Hgene | SOD1 | C0003493 | Aortic Diseases | 1 | CTD_human |
Hgene | SOD1 | C0004045 | Asphyxia Neonatorum | 1 | CTD_human |
Hgene | SOD1 | C0004096 | Asthma | 1 | CTD_human |
Hgene | SOD1 | C0004153 | Atherosclerosis | 1 | CTD_human |
Hgene | SOD1 | C0005586 | Bipolar Disorder | 1 | PSYGENET |
Hgene | SOD1 | C0007786 | Brain Ischemia | 1 | CTD_human |
Hgene | SOD1 | C0011616 | Contact Dermatitis | 1 | CTD_human |
Hgene | SOD1 | C0011849 | Diabetes Mellitus | 1 | CTD_human |
Hgene | SOD1 | C0011853 | Diabetes Mellitus, Experimental | 1 | CTD_human |
Hgene | SOD1 | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | CTD_human |
Hgene | SOD1 | C0011884 | Diabetic Retinopathy | 1 | CTD_human |
Hgene | SOD1 | C0013080 | Down Syndrome | 1 | CTD_human |
Hgene | SOD1 | C0015696 | Fatty Liver, Alcoholic | 1 | CTD_human |
Hgene | SOD1 | C0015934 | Fetal Growth Retardation | 1 | CTD_human |
Hgene | SOD1 | C0017638 | Glioma | 1 | CTD_human |
Hgene | SOD1 | C0018801 | Heart failure | 1 | CTD_human |
Hgene | SOD1 | C0019054 | Hemolysis (disorder) | 1 | CTD_human |
Hgene | SOD1 | C0019189 | Hepatitis, Chronic | 1 | CTD_human |
Hgene | SOD1 | C0020550 | Hyperthyroidism | 1 | CTD_human |
Hgene | SOD1 | C0020649 | Hypotension | 1 | CTD_human |
Hgene | SOD1 | C0020672 | Hypothermia, natural | 1 | CTD_human |
Hgene | SOD1 | C0021368 | Inflammation | 1 | CTD_human |
Hgene | SOD1 | C0022116 | Ischemia | 1 | CTD_human |
Hgene | SOD1 | C0022650 | Kidney Calculi | 1 | CTD_human |
Hgene | SOD1 | C0023895 | Liver diseases | 1 | CTD_human |
Hgene | SOD1 | C0024796 | Marfan Syndrome | 1 | CTD_human |
Hgene | SOD1 | C0025312 | Meningomyelocele | 1 | CTD_human |
Hgene | SOD1 | C0026846 | Muscular Atrophy | 1 | CTD_human |
Hgene | SOD1 | C0027051 | Myocardial Infarction | 1 | CTD_human |
Hgene | SOD1 | C0027540 | Necrosis | 1 | CTD_human |
Hgene | SOD1 | C0027720 | Nephrosis | 1 | CTD_human |
Hgene | SOD1 | C0027765 | nervous system disorder | 1 | CTD_human |
Hgene | SOD1 | C0028754 | Obesity | 1 | CTD_human |
Hgene | SOD1 | C0033626 | Protein Deficiency | 1 | CTD_human |
Hgene | SOD1 | C0033687 | Proteinuria | 1 | CTD_human |
Hgene | SOD1 | C0036330 | Schistosomiasis mansoni | 1 | CTD_human |
Hgene | SOD1 | C0036341 | Schizophrenia | 1 | PSYGENET |
Hgene | SOD1 | C0036457 | Scrapie | 1 | CTD_human |
Hgene | SOD1 | C0038454 | Cerebrovascular accident | 1 | CTD_human |
Hgene | SOD1 | C0041408 | Turner Syndrome | 1 | CTD_human |
Hgene | SOD1 | C0085084 | Motor Neuron Disease | 1 | CTD_human |
Hgene | SOD1 | C0162316 | Iron deficiency anemia | 1 | CTD_human |
Hgene | SOD1 | C0162671 | MELAS Syndrome | 1 | CTD_human |
Hgene | SOD1 | C0162674 | Chronic progressive external ophthalmoplegia | 1 | CTD_human |
Hgene | SOD1 | C0751830 | Gait Disorders, Neurologic | 1 | CTD_human |
Hgene | SOD1 | C0919267 | ovarian neoplasm | 1 | CTD_human |
Hgene | SOD1 | C1262477 | Weight decreased | 1 | CTD_human |
Hgene | SOD1 | C1384666 | hearing impairment | 1 | CTD_human |
Hgene | SOD1 | C1456865 | Ureteral Calculi | 1 | CTD_human |
Hgene | SOD1 | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
Tgene | CXCL9 | C0002171 | Alopecia Areata | 1 | CTD_human |
Tgene | CXCL9 | C0020517 | Hypersensitivity | 1 | CTD_human |
Tgene | CXCL9 | C0023892 | Biliary cirrhosis | 1 | CTD_human |
Tgene | CXCL9 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Tgene | CXCL9 | C0023904 | Liver Neoplasms, Experimental | 1 | CTD_human |
Tgene | CXCL9 | C0027643 | Neoplasm Recurrence, Local | 1 | CTD_human |
Tgene | CXCL9 | C0032285 | Pneumonia | 1 | CTD_human |
Tgene | CXCL9 | C0282488 | Interstitial Cystitis | 1 | CTD_human |
Tgene | CXCL9 | C0345967 | Malignant mesothelioma | 1 | CTD_human |
Tgene | CXCL9 | C1458155 | Mammary Neoplasms | 1 | CTD_human |